Business / Finance

RSS
MyFitnessPal closes $18 million Series to improve health and wellness of millions of users

MyFitnessPal closes $18 million Series to improve health and wellness of millions of users

Omeros announces financial results for second quarter of 2013

Omeros announces financial results for second quarter of 2013

New reagent kits for intracellular staining from Beckman Coulter Life Sciences

New reagent kits for intracellular staining from Beckman Coulter Life Sciences

TruClinic signs new partnership with University of Utah Hospital's Department of Telemedicine

TruClinic signs new partnership with University of Utah Hospital's Department of Telemedicine

FitBionic completes $2.2M funding round with KMG Capital Partners, CID4 and High Country Venture

FitBionic completes $2.2M funding round with KMG Capital Partners, CID4 and High Country Venture

MAXIMUS revenue grows 26% to $334.3 million in Q3 2013

MAXIMUS revenue grows 26% to $334.3 million in Q3 2013

Lupin acquires exclusive license to promote, distribute Romark's Alinia for Oral Suspension in US

Lupin acquires exclusive license to promote, distribute Romark's Alinia for Oral Suspension in US

Molex signs definitive agreements to acquire FCT Electronics Group

Molex signs definitive agreements to acquire FCT Electronics Group

CVS Caremark net revenues increase 1.7% in Q2 2013

CVS Caremark net revenues increase 1.7% in Q2 2013

Targacept reports net loss of $12.4 million for Q2 2013

Targacept reports net loss of $12.4 million for Q2 2013

Portage Health inks definitive agreement to form joint venture with LifePoint Hospitals

Portage Health inks definitive agreement to form joint venture with LifePoint Hospitals

TTY BIOPHARM receives Outstanding Company of the Year award

TTY BIOPHARM receives Outstanding Company of the Year award

Ensemble Therapeutics initiates research and development collaboration with Novartis

Ensemble Therapeutics initiates research and development collaboration with Novartis

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

Compugen, Bayer sign collaboration and license agreement for antibody-based cancer immunotherapies

Compugen, Bayer sign collaboration and license agreement for antibody-based cancer immunotherapies

MEDNAX acquires Holston Anesthesia Associates

MEDNAX acquires Holston Anesthesia Associates

Nubreed Nutrition teams up with legendary bodybuilder Lee Priest

Nubreed Nutrition teams up with legendary bodybuilder Lee Priest

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.